Prevention of Chemotherapy-induced Myelosuppression Terminated Phase 1 Trials for Sulanemadlin (DB17285)
| Indication | Status | Phase |
|---|---|---|
| DBCOND0152877 (Prevention of Chemotherapy-induced Myelosuppression) | Terminated | 1 |
| clinicaltrials.gov Identifier | Title | Purpose | Drugs |
|---|---|---|---|
| NCT05622058 | A Study of ALRN-6924 for Protection of Chemotherapy-Induced Side Effects in Patients With TP53-Mutant Breast Cancer | Prevention |